Cybrdi, Inc. Stock

CYDI

US23254K1007

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-50.91%

17-10-30	Xi’an Alena Biotechnology Co., Ltd completed the acquisition of 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc..	CI
17-07-18	Xi’an Alena Biotechnology Co., Ltd entered into a share transfer agreement to acquire 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc. for CNY 25.6 million.	CI

Cybrdi Inc is a united states-based company, which operates as a holding company. The Company's subsidiaries include Chaoying Biotech which is engaged in biotechnology manufacturing, and research and development company. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a Cultural and Entertainment company. Its key product is tissue chips, intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. The Companyâ€™s Tissue Microarrays (TMAs) segment offers a variety of tissue array products and services on the commercial market. The Technical Services segment provides in-house technical services platform to perform customized research according to customer specifications. The Culture, Entertainment, and Real Estate Business segment is developing a Culture and Entertainment Square in Changle City of Shandong Province.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
CYDI Stock

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	2.52M 2.22M 2.04M 1.91M 3.58M 238M 3.65M 24.52M 9.5M 117M 9.48M 9.27M 408M	P/E 2012	-1.82x	P/E 2013	-2.85x
Enterprise Value	6.51M 5.72M 5.27M 4.93M 9.25M 615M 9.42M 63.26M 24.5M 303M 24.46M 23.93M 1.05B	EV / Sales 2012	3.25x	EV / Sales 2013	9.67x
Free-Float	29.19%	Yield 2012 *	-	Yield 2013	-

Manager	Title	Age	Since
Yan Biao Bai CEO	Chief Executive Officer	63	2002-12-31
Yong Hong Ren COO	Chief Operating Officer	-	2011-08-18

Director	Title	Age	Since
Yan Biao Bai CHM	Chairman	63	2002-12-31
Yong Hong Ren BRD	Director/Board Member	-	2011-08-18

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYBRDI, INC.	-.--%	-.--%	-	-	325K
LONZA GROUP AG	+1.67%	+9.28%	-5.05%	+1.40%	45.45B
REVOLUTION MEDICINES, INC.	+4.95%	+9.31%	+363.86%	+598.16%	36.09B
IQVIA HOLDINGS INC.	+0.44%	+11.12%	+17.47%	-12.91%	30.98B
BEONE MEDICINES AG	-0.64%	+1.92%	+3.08%	+53.58%	30.81B
CELLTRION, INC.	+0.23%	-0.29%	+13.24%	+21.10%	24.62B
ASCENDIS PHARMA A/S	+9.90%	+13.32%	-	-	14.78B
MEDPACE HOLDINGS, INC.	+1.40%	+12.99%	+67.11%	+132.76%	14.65B
EUROFINS SCIENTIFIC SE	+1.88%	+8.59%	+13.76%	+20.68%	13.3B
IONIS PHARMACEUTICALS, INC.	+2.38%	+5.69%	+95.85%	+97.63%	12.65B
Average	+2.22%	+6.06%	+71.16%	+114.05%	22.33B
Weighted average by Cap.	+2.13%	+6.77%	+77.89%	+128.88%

	2012	2013
Net sales	783K 688K 634K 593K 1.11M 73.9M 1.13M 7.6M 2.95M 36.43M 2.94M 2.88M 127M	574K 504K 465K 435K 815K 54.19M 830K 5.58M 2.16M 26.71M 2.16M 2.11M 92.83M
Net income	-530K -465K -429K -401K -752K -49.99M -766K -5.14M -1.99M -24.64M -1.99M -1.95M -85.64M	-548K -482K -444K -415K -778K -51.74M -793K -5.32M -2.06M -25.51M -2.06M -2.01M -88.64M
Net Debt	1.58M 1.39M 1.28M 1.2M 2.25M 149M 2.29M 15.37M 5.95M 73.64M 5.95M 5.81M 256M	3.99M 3.5M 3.23M 3.02M 5.66M 376M 5.77M 38.74M 15.01M 186M 14.98M 14.65M 645M

Cybrdi, Inc. Stock

Stocks

CYDI

US23254K1007

Biotechnology & Medical Research

Valuation: Cybrdi, Inc.

Latest news : Cybrdi, Inc.

Managers and Directors: Cybrdi, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile